Biomedical Engineering Reference
In-Depth Information
210. Meyer zu Schwabedissen HE, Grube M, Heydrich B, Linnemann K, Fusch C, Kroemer
HK, Jedlitschky G. 2005. Expression, localization, and function of MRP5 (ABCC5), a
transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts:
effects of gestational age and cellular differentiation. Am J Pathol 166:39-48.
211. Leonard GD, Fojo T, Bates SE. 2003. The role of ABC transporters in clinical practice.
Oncologist 8:411-424.
212. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. 2006. Targeting
multidrug resistance in cancer. Nat Rev Drug Discov 5:219-234.
213. Chan HS, Lu Y, Grogan TM, Haddad G, Hipfner DR, Cole SP, Deeley RG, Ling V, Gallie
BL. 1997. Multidrug resistance protein (MRP) expression in retinoblastoma correlates
with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein.
Cancer Res 57:2325-2330.
214. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL, Haber M. 1996. Expression
of the gene for multidrug-resistance-associated protein and outcome in patients with
neuroblastoma. N Engl J Med 334:231-238.
215. Nooter K, Westerman AM, Flens MJ, Zaman GJ, Scheper RJ, van Wingerden KE, Burger
H, Oostrum R, Boersma T, Sonneveld P. 1995. Expression of the multidrug resistance-
associated protein (MRP) gene in human cancers. Clin Cancer Res 1:1301-1310.
216. Filipits M, Malayeri R, Suchomel RW, Pohl G, Stranzl T, Dekan G, Kaider A, Stiglbauer
W, Depisch D, Pirker R. 1999. Expression of the multidrug resistance protein (MRP1) in
breast cancer. Anticancer Res 19:5043-5049.
217. Filipits M, Suchomel RW, Dekan G, Stiglbauer W, Haider K, Depisch D, Pirker R.
1997. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal
carcinomas. Br J Cancer 75:208-212.
218. Takebayashi Y, Akiyama S, Natsugoe S, Hokita S, Niwa K, Kitazono M, Sumizawa T,
Tani A, Furukawa T, Aikou T. 1998. The expression of multidrug resistance protein in
human gastrointestinal tract carcinomas. Cancer 82:661-666.
219. Alexander D, Yamamoto T, Kato S, Kasai S. 1999. Histopathological assessment of mul-
tidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-
associated protein, and lung-resistance protein. Surg Today 29:401-406.
220. Plaat BE, Hollema H, Molenaar WM, Torn Broers GH, Pijpe J, Mastik MF, Hoekstra HJ,
van den Berg E, Scheper RJ, van der Graaf WT. 2000. Soft tissue leiomyosarcomas and
malignant gastrointestinal stromal tumors: differences in clinical outcome and expression
of multidrug resistance proteins. J Clin Oncol 18:3211-3220.
221. Theou N, Gil S, Devocelle A, Julie C, Lavergne-Slove A, Beauchet A, Callard P, Farinotti
R, Le Cesne A, Lemoine A, Faivre-Bonhomme L, Emile JF. 2005. Multidrug resistance
proteins in gastrointestinal stromal tumors: site-dependent expression and initial response
to imatinib. Clin Cancer Res 11:7593-7598.
222. Abe T, Mori T, Wakabayashi Y, Nakagawa M, Cole SP, Koike K, Kuwano M, Hori
S. 1998. Expression of multidrug resistance protein gene in patients with glioma after
chemotherapy. J Neurooncol 40:11-18.
223. Mohri M, Nitta H, Yamashita J. 2000. Expression of multidrug resistance-associated
protein (MRP) in human gliomas. J Neurooncol 49:105-115.
224. Tews DS, Nissen A, Kulgen C, Gaumann AK. 2000. Drug resistance-associated factors in
primary and secondary glioblastomas and their precursor tumors. J Neurooncol 50:227-
237.
Search WWH ::
Custom Search